Email this page
Print this page
Extra Views
Telling Cells How to Die: Docetaxel Therapy in Cancer Cell Lines
Héctor Hernández-Vargas, José Palacios and Gema Moreno-Bueno
Volume 6, Issue 7April 1, 2007
Pages 780 - 783
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDF
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Taxanes (paclitaxel and docetaxel) are antimicrotubule agents used in the clinical practice for the treatment of solid tumors. The molecular mechanisms of taxane-dependent cytotoxicity are only partially known. In vitro, different modes of action have been established for paclitaxel according to its concentration. A similar phenomenon has been shown for other microtubule-stabilizing drugs, including docetaxel. Recently, we described two different forms of mitotic exit in breast cancer cell lines exposed to docetaxel. The causes and consequences of the dual mechanism of cytotoxicity of this agent are discussed here.
Authors
- Héctor Hernández-Vargas
- Spanish National Cancer Centre; Madrid, Spain
- José Palacios
- Servicio de Anatomía Patológica; Sevilla, Spain
- Gema Moreno-Bueno
- Instituto de Investigaciones Biomedicas Alberto Sols; Madrid, Spain
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDF
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
